These compounds may interact with:

Tyrosine-protein kinase JAK3

Potentially involved in: severe combined immunodeficiency; immune system cancer; lymphoid leukemia; kidney cancer; carcinoma; cancer; rheumatoid arthritis; polycythemia vera; lactocele; diarrhea; intestinal obstruction; meningitis; pneumonia; lymph node abnormality; failure to gain weight; juvenile myelomonocytic leukemia; recurrent upper respiratory tract infection; panhypogammaglobulinemia; severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negative; lack of delayed skin hypersensitivity reaction

Disease data sourced from Pharos.